Cargando…

Integrase inhibitor-based treatment in clinical practice

Detalles Bibliográficos
Autores principales:	Cenderello, G, Piscopo, R, Feasi, M, Penco, G, Bobbio, N, Cassola, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113034/ http://dx.doi.org/10.1186/1758-2652-13-S4-P32

Ejemplares similares

Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations
por: Nguyen, Nga, et al.
Publicado: (2013)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Docking studies of flavonoid derivatives as potent HIV-1 integrase inhibitors
por: Premjanu, N, et al.
Publicado: (2014)

Monoclonal antibodies that recognize important functional elements of the HIV-1 integrase enzyme
por: Maroun, Richard G, et al.
Publicado: (2012)

PIAS3 modulate HIV-1 integrase SUMOylation
por: Beauclair, Guillaume, et al.
Publicado: (2011)

GCN5-dependent acetylation of HIV-1 integrase enhances viral integration
por: Terreni, Mariaelena, et al.
Publicado: (2009)

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: results from a multicenter study
por: Madeddu, G, et al.
Publicado: (2010)

Phase I / II trial of dose adjusted EPOCH chemotherapy with bortezomib combined with integrase inhibitor therapy for HTLV-1 associated T-cell leukemia lymphoma
por: Ratner, Lee, et al.
Publicado: (2015)

Identification of SFPQ as novel interacting partner of HIV-1 Integrase and its functional characterization
por: Sur, Souvik, et al.
Publicado: (2012)

2-Hydroxyisoquinoline-1,3(2H, 4H)diones (HQDs), novel inhibitors of the HIV integrase catalytic activity with a high barrier to resistance
por: Christ, Frauke, et al.
Publicado: (2013)

Comparative biochemical analysis of wildtype and drug resistant HIV-1 integrase subtypes B and C
por: Bar-Magen, Tamara, et al.
Publicado: (2009)

HIV-1 acetylated integrase is targeted by KAP1 (TRIM28) to inhibit viral integration
por: Allouch, Awatef, et al.
Publicado: (2009)

Guillain-Barré Syndrome with Fatal Outcome during HIV-1-Seroconversion: A Case Report
por: Pontali, Emanuele, et al.
Publicado: (2011)

1005. Comparison of Weight Changes in Treatment-Naïve, HIV-Infected Patients Receiving Integrase Inhibitor-Based Therapy Versus Protease Inhibitor-Based Therapy
por: Howe, Zachary, et al.
Publicado: (2020)

Reasons for using and efficacy of raltegravir in salvage regimens without protease inhibitors in clinical practice
por: Llibre, JM, et al.
Publicado: (2010)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
por: Koneru, Pratibha C, et al.
Publicado: (2019)

PReS-FINAL-2324: PAPA syndrome clinical spectrum and IL-1Β release
por: Omenetti, A, et al.
Publicado: (2013)

Sepsis-induced lung fibrosis in baboons is reduced by the treatment with a complement inhibitor
por: Lupu, F, et al.
Publicado: (2011)

946. Risk factors and Metabolic Implications of Integrase Inhibitor Associated Weight Gain
por: Asundi, Archana, et al.
Publicado: (2020)

952. Weight-Gain in Treatment Naive Newly Diagnosed HIV-Infected Persons After Initiation on Integrase Strand Inhibitor Based Treatment Regimens
por: Szep, Zsofia, et al.
Publicado: (2020)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

'Sexual addiction': diagnosis and treatment in clinical practice
por: Hughes, B
Publicado: (2012)

A multinational, drug utilisation study to investigate the use of dexmedetomidine (DEXDOR®) in clinical practice in the EU
por: Garratt, C, et al.
Publicado: (2015)

The use of integrase inhibitors in treatment-experienced patients
por: Gatell, Jose M
Publicado: (2009)

Resistance to Integrase Inhibitors
por: Métifiot, Mathieu, et al.
Publicado: (2010)

HIV drug resistance profile of HIV-1 CRF 01_AE protease and integrase coding regions in HIV infected Cambodian patients failing LPV-based 2(nd) line antiretroviral regimen
por: Nouhin, Janin, et al.
Publicado: (2011)

P09-11. Reduced replication capacity of NL4-3 chimeric viruses encoding RT-Integrase sequences from HIV-1 elite controllers
por: Li, C, et al.
Publicado: (2009)

1043. The impact of integrase strand transfer inhibitors (InSTIs) on weight gain among adults with HIV in clinical care
por: Thatipelli, Sneha, et al.
Publicado: (2020)

889. Early Discontinuations and Adverse Events Among Treatment-Naïve Patients Initiating Integrase Inhibitors in a Real-world Setting
por: Rolle, Charlotte-Paige M, et al.
Publicado: (2021)

Effect of C1-esterase inhibitor treatment on microcirculatory perfusion after superior mesenteric artery ischemia
por: Lauterbach, M, et al.
Publicado: (2007)

HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
por: Foster, Emma G., et al.
Publicado: (2022)

HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa
por: Gottlieb, Geoffrey S., et al.
Publicado: (2011)

Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
por: Vilaplana, Vicente Escudero, et al.
Publicado: (2010)

The Brody effect to detect hypovolemia in clinical practice
por: Giraud, R, et al.
Publicado: (2012)

P17-12. Immunogenicity comparison of dna vaccines encompassing HIV-1 tat, rev, integrase (C-half), vif and nef genes derived from different clades
por: Wan, Y, et al.
Publicado: (2009)

Clinical-experimental assessment of simvastatin efficiency in the treatment of rheumatoid arthritis
por: Tadjikhodjaeva, Rikhikhon N, et al.
Publicado: (2012)

P03.02. From CAM practice to CAM research: a bridge fellowship for CAM practitioners to pursue careers in clinical research
por: Evans, R, et al.
Publicado: (2012)

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012)

German evidence and consensus based guidelines 2010 for the treatment of juvenile idiopathic arthritis (JIA)
por: Dueckers, G, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_jr9ced49klalhae0md68r32g64